A new Danish study may be the first step towards a much faster and more accurate diagnosis of a wide range of conditions that require regulation of the body's stress hormone, cortisol.
Mar 1, 2024
0
43
Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients' T cells so they can better find and destroy tumor cells. But CAR-T cell therapy doesn't work well in every cancer—including ...
Mar 1, 2024
0
9
UdeM's Stéphanie Forté and co-researchers in Canada and Brazil have shown how people with sickle cell disease or sickle cell trait have a higher chance of dying from COVID-19 than the general population.
Feb 29, 2024
0
1
Regulators on Wednesday said materials with harmful chemicals known as "PFAS" are no longer being sold to package microwave popcorn or other greasy foods in the United States.
Feb 29, 2024
0
0
The weight of the opioid crisis is heavy.
Feb 27, 2024
0
0
Eye ointment products made in India and sold in the United States at Walmart, CVS and other retailers are being recalled due to a danger of infection.
Feb 27, 2024
0
0
When an autopsy revealed that actor Matthew Perry died of "acute effects of ketamine," it put fresh attention on an ongoing debate in the field of psychiatry: What's the right balance between expanding access to a drug that ...
Feb 27, 2024
0
32
Vapers are susceptible to infection by SARS-CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a study by a research team at University of California, Riverside, has found.
Feb 26, 2024
0
20
The first time Elizabeth Ondula thought about using technology to improve public health was when she faced a personal tragedy during the COVID-19 pandemic. Her father died and she was unable to travel for his burial due to ...
Feb 26, 2024
0
0
A genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis has been approved for reimbursement by the Centers for Medicare ...
Feb 26, 2024
0
1
